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Abstract
Background: Several papers have discussed which effect measures are appropriate to capture the contrast
between exposure groups in cross-sectional studies, and which related multivariate models are suitable. Although
some have favored the Prevalence Ratio over the Prevalence Odds Ratio – thus suggesting the use of log-binomial
or robust Poisson instead of the logistic regression models – this debate is still far from settled and requires close
scrutiny.
Discussion: In order to evaluate how accurately true causal parameters such as Incidence Density Ratio (IDR) or
the Cumulative Incidence Ratio (CIR) are effectively estimated, this paper presents a series of scenarios in which a
researcher happens to find a preset ratio of prevalences in a given cross-sectional study. Results show that,
provided essential and non-waivable conditions for causal inference are met, the CIR is most often inestimable
whether through the Prevalence Ratio or the Prevalence Odds Ratio, and that the latter is the measure that
consistently yields an appropriate measure of the Incidence Density Ratio.
Summary: Multivariate regression models should be avoided when assumptions for causal inference from cross-
sectional data do not hold. Nevertheless, if these assumptions are met, it is the logistic regression model that is
best suited for this task as it provides a suitable estimate of the Incidence Density Ratio.
Background
Mainstream books devoted to organizing knowledge on
epidemiological methods used to emphasize the study of
the distribution of health events according to person,
time and place [1,2]. Following a period when vital sta-
tistics were the main data sources for this aim, cross-
sectional studies began to play an important role in this
field providing prevalence aggregate and group-specific
estimates.
Acknowledging the limitations of prevalence vis-à-vis
incidence estimations in some circumstances, from the
1980’s, a particular literature focused on cross-sectional
data as a means to indirectly obtain the estimations of
incidence rates [3-8]. Simultaneously, following a
growing interest of the epidemiological community on
causal inference [9,10], cross-sectional studies were not
only accepted as a way of estimating prevalences, but
given certain conditions, also as a suitable design for
investigating causal relationships. Since the 1990’s,
papers recognizing the analytical role of epidemiological
surveys have been concerned with two issues: (i) which
measure would be appropriate for capturing the contrast
between exposure groups, whether the prevalence ratio
(PR) or the prevalence odds ratio (POR); and (ii) which
model should be used for estimating these quantities in
the multivariate context.
The first issue raised a debate which split two camps.
Whereas Strömberg [11,12] favored the POR, Lee &
Chia [13,14], Lee [15], Axelson et al. [16,17] and
Thompson et al. [18] argued that the estimator was dif-
ficult to interpret and communicate; was very discrepant
from PR when outcomes were common; and that the
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ratio (IDR) – stationarity and equal duration of disease –
were hardly met. Reservations were also expressed on
the account that the POR was a numerical mimic to
other effect measures; and was misinterpreted as cumu-
lative incidence ratio (CIR) in the presence of common
outcomes.
Although Pearce [19] – again favoring the POR –
revisited the dispute only a few years ago, the debate per
se seemed to have died away, being outshined by the
second contention, namely, as to which methods would
be best to model prevalence data. Since surveys most
often involve frequent events, several authors called up
the ‘rare disease assumption’ [20,21] and argued that the
POR obtained by logistic regression model would thus
overestimate the PR. As an extension, statistical models
other than logistic regression have been proposed to
estimate PR, namely, the log-binomial, Poisson or Cox
models with robust variance estimates [18,22-26]. Sev-
eral studies have taken this on and have been effectively
using these models to handle data arising from cross-
sectional data and envisaging control for confounding
variables. For instance, a preliminary and tentative lit-
erature search in Medline (October 8, 2009) using the
keywords ("prevalence ratio*"[All Fields] OR “cross-sec-
tional"[All Fields]) AND (Poisson[All Fields] OR “log-
binomial"[All Fields]) AND “humans"[MeSH Terms]
found 444 references of this kind. Conspicuously, the
numbers increased from 20 papers between 1990-1994,
to 262 in the 2005-2009 period.
It is our contention that this perspective is essentially
misguided and that a discussion on the best model only
makes sense if preceded by a thorough debate about
what is actually sought with a cross-sectional study: esti-
mating the magnitude of a condition in a population or
making causal inference? The purpose of this paper is
thus to revisit a dispute that, though hardly new by any
means, is far from settled. In fact, our motivation has
been this growing literature that utilizes multivariate
models for PR to address relationships between a
‘dependent’ and several ‘independent’ variables, yet in
our view without a clear-cut supporting rationale behind
it.
Discussion
To address our contention, this section is organized as
follows. The first subsection provides a brief review
regarding the purposes of cross-sectional studies, with a
particular eye on identifying the specific situations when
measures of association based on information gathered
from cross-sectional studies are in fact wanted and/or
required, and when multivariate modeling procedures
are hence due. The ensuing subsection dwells on the
relation between prevalence and incidence ratio
measures. It starts by presenting the necessary condi-
tions whereby a cross-sectional study may be able to
provide measures of effect representing causal para-
meters. Next, in preparation to the proposed scenarios
and discussions that follow, an outline on the formal
relations between measures originating from cross-
sectional approaches (PR and POR) and respective rela-
tions to causal parameters – t h ec u m u l a t i v ei n c i d e n c e
ratio and the incidence density ratio (IDR) – are pro-
vided. In sequence we create several scenarios that prag-
matically assume that data come from surveys (as in so
many real instances) and enquire whether and how the
actual obtained measures (PR or POR) effectively inform
about either CIR or IDR. The next subsection offers the
rationale for choosing a suitable multivariable model,
followed by a subsection building upon the arguments
provided previously and proposing a decision tree for
analyzing cross-sectional data. Finally, in the light of our
own insights, the last subsection of the Discussion revi-
sits some of the points mentioned in the Background
section for and against the measures and models used
for causal inference in cross-sectional studies.
Purposes of a cross-sectional studies
Before delving into a debate about which multivariate
model to use, a key issue in deciding between contrast
measures (PR or POR) concerns the underlying reason
for actually wanting to obtain ratios involving estimates
in cross-sectional studies. To answer this question one
needs to summon up the two main purposes for carry-
ing out health surveys.
The most usual and uncontroversial is to provide
overall and group-specific prevalences of a particular
health event in a given population, usually with an out-
look to help organizing resources and to guide decision-
making processes. In this particular case, estimating a
PR – or more precisely, a single-value estimate contrast-
ing the prevalences obtained in two population strata –
may not be of much interest. Concretely, what would a
health officer make of being informed that the PR
equals 2.0 in a particular population? This value could
signify, for example, that the magnitude of an event of
interest in two different strata is 20% and 10%, but may
also relate to prevalences of 0.02% and 0.01%, respec-
tively. Clearly, these are very different scenarios in terms
of relevance and resulting health actions, which an
o m n i b u sm e a s u r ea st h i sP Ro f2 . 0s i m p l yf a i l st o
portray.
This also reminds us that when causal inference is not
desired or possible (c.f. subsection “Structuring condi-
tions” further on) the knowledge regarding tangible
magnitudes of specific prevalences is much more infor-
mative than their ratio. It follows that statistical model-
ing to ‘adjust for several variables’ may also provide
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stances. An exception is when it is unfeasible to directly
calculate estimates of prevalence due to data sparseness
within subgroups, especially if there are specific target
groups to be identified for further action. In order to
get around this problem, it is possible to resort to multi-
variate modeling to predict or project prevalences (prob-
abilities) using, for instance, a logistic model and
thereafter applying the anti-logit function
Pr P X ii i
k () =+ − + ( ) =
−
∑ 1 0 1
1
exp ( )  ,w i t hk vari-
ables describing patterns of characteristics in these sub-
groups. Still, it important to realize that in this
particular situation one is neither modeling nor inter-
ested in any effect (ratio) measure, but rather in the
actual probabilities/prevalences occurring in – or rather,
projected for – certain subgroups of interest.
Another purpose of surveys is to uncover causal rela-
tionships. Although longitudinal study designs are bet-
ter suited for this aim, cross-sectional studies have
often been used to answer causal questions, mostly for
pragmatic reasons such as unavailability of incidence
data, reducing cost and duration of a study, and some-
times because of ethical constraints, as for instance,
when a detected exposure unequivocally needs
immediate intervention, rendering a ‘neutral’ follow up
unsustainable.
Now, if the purpose of a survey is to address a cau-
sal relation, one of the key issues required for dealing
with observational data concerns the modeling proce-
dure. Yet, ahead of engaging in modeling the ‘natural
estimator’ yielded in a survey (e.g., PR for some), one
has to step back and ask what is really being achieved
by controlling for several co-variables. Specifically in
the context depicted here, the question is why a
researcher would want to obtain the average preva-
lence ratio accounting for the other variables in the
model. One answer would be to ‘recover’ ac o u n t e r f a c -
tual estimation that contrasts the exposed with ‘them-
selves if unexposed’ regarding the outcome of interest,
which is only empirically achieved by comparing the
exposed with the actual unexposed, once the effect of
other relevant factors are explained away. This is evi-
dently (and not surprisingly to most readers) a way to
deal with confounding within the perspective of what
has been labeled the potential-outcome model [27,28].
If this is indeed a reasonable model, what would the
required estimator(s) then be? Would a ratio of two
prevalences (which, inter alia, may conflate incidence
and duration of the event) suffice or would its ulti-
mate aim be to estimate risk ratios (CIR) or rate ratios
(IDR) given both are recognizably ‘true’ causal para-
meters and largely recommended as the appropriate
quantities to be attained [9,29]? If the latter, an essen-
tial task is to scrutinize as to when and how a survey
is effectively able to produce measures that are cap-
able of representing any of these two causal
parameters.
Relating prevalence and incidence ratio measures
Structuring conditions
At the outset, five conditions are necessary for a cross-
sectional approach to be able to investigate an etiologi-
cal hypothesis, and without which any attempt to relate
an ensuing estimator to either the CIR or IDR breaks
down. For one, the population must be in steady state
over the study period (stationary). In this case, within
any given period of time, the size of the population
needs to be constant across the exposure groups, as well
as in regards to any other co-variable used in the mod-
eling process. Secondly, no selective survival is allow-
able, i.e., the probability of withdrawal or death from
the outcome under study or from other related causes
may not be different across exposure groups. Thirdly,
the mean duration of the outcome must be the same
regardless of exposure group, that is, the exposure may
not differentially influence the survival or recovery prob-
abilities. Fourthly, no reverse causality is allowed, i.e.,
the outcome being modeled may not reciprocally cause
(influence) the exposure status in any way. Lastly, the
temporal directionality from the exposure to the out-
come must be sustainable, either theoretically (e.g., if a
lifelong attribute is studied as the exposure for a recent
outcome event) or by means of a thorough data collec-
tion procedure that assures the exposure as an antece-
dent of the outcome (e.g., in a study on the effects on
child birth, recalling at birth a past exposure during
pregnancy) [9,30].
Once these criteria are exhaustively met, the next step
consists of inspecting the conditions whereby the esti-
mates obtained in cross-sectional studies capture causal
parameters or, in contrast and most importantly, under
which circumstances they fall apart.
Formal relations between measures
Recalling Kleinbaum et al. [9] and notation therein, let
RC I tti tti (, ) , (, ) , 00 = be the risk or the cumulative inci-
dence of an outcome of interest (e.g., disease, illness)
occurring in stratum i within a time interval Δt =( t0, t);
IDi be the respective incidence density; Ti be the mean
duration of the outcome; and Pi the point prevalence
measured (obtained) through a cross-sectional approach.
Dropping the subscript (t0, t) for ease of notation,
define
CI ID t ii =− − [] 1 exp ( )  Δ (1)
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ID
CIi
t
i =
− () ⎡ ⎣ ⎤ ⎦ ln
.
11
Δ
(2)
Since, generically, the relation between incidence
density and prevalence is
P
IDiTi
IDiTi
i =
+1
, (3)
the ensuing prevalence ratio is
PR
P
P
ID T ID T
ID T ID T
==
+ ()
+ ()
1
0
11 111
00 001
. (4)
Hence, if according to equation (2) one has ID0 =[ l n ( 1 / ( 1
- CI0))]/Δt for the unexposed and ID1 =[ l n ( 1 / ( 1-CI1))]/Δt
for the exposed, further substituting these quantities into
equation (3), the ensuing prevalences are, respectively,
P
CI t T
CI t T
0
11 00
11 00 1
=
− [] ()
− [] () () +
ln /( )
ln /( )
Δ
Δ
 
 
(5)
P
CI t T
CI t T
1
11 11
11 11 1
=
− [] ()
− [] () () +
ln /( )
ln /( )
Δ
Δ
 
 
(6)
and, thus, the prevalence ratio (PR) may also be writ-
ten as a function of the underlying risks (CIi)a n do u t -
come durations Ti as
PR
CI T CI T t
CI T
 = 
ln /( ) ln /( )
ln /( )
11 11 11 00
11 0
− [] ⋅⋅ − [] ⋅+ ()
− [] ⋅
Δ
0 0 11 11 ⋅− [] ⋅+ () ln /( ) CI T t Δ
(7)
From equation (3), IDi may be expressed as a function
of an estimated prevalence
ID
Pi
Pi Ti
i =
− (1 ) 
(8)
and, therefore,
IDR
ID
ID
PP
PP
T
T
==
−
−
⎛
⎝
⎜
⎞
⎠
⎟ 1
0
1 1 1
0 1 0
0
1
()
()
(9)
Note that the IDR g i v e ni ne q u a t i o n( 9 )m a ya l s ob e
written as a function of the prevalence odds-ratio
IDR POR
T
T
=
⎛
⎝
⎜
⎞
⎠
⎟ 0
1
(10)
and when the outcome durations are the same in both
strata (exposed and non-exposed), the IDR equals the
POR.
The CIi may also be expressed from the prevalence Pi.
Solving equation (5) or (6), generically for stratum i, one
has
 CI
Pi t
Ti PiTi
i =− −
−
⎛
⎝
⎜
⎞
⎠
⎟ 1 exp
Δ
(11)
and therefore,
CIR
Pt
TP T
Pt
TP T
=
−−
−
⎛
⎝
⎜
⎞
⎠
⎟
−−
−
⎛
⎝
⎜
⎞
⎠
⎟
1 1
11 1
1 0
00 0
exp
exp
Δ
Δ
(12)
All results in the following subsection (including fig-
ures) were obtained through an ad hoc Stata® program
(epiconv ado-file) based on the above relations. The
routine may be obtained with one of the authors (MER)
on request.
Exploring several scenarios
The scenarios that follow assume that data are collected
through cross-sectional approaches and that the ratios
of effectively measured prevalences between exposed
and unexposed are always 2.0. Bearing a causal outlook,
the fundamental issue concerns the interpretation in
terms of the experience of the population under investi-
gation. In the light of some or even all of the conditions
presented (c.f. subsection “Structuring conditions”), how
are the estimates to be read? What do they signify in
terms of CI and ID, and by extension, their related
effect measures CIR and IDR?
The scenarios portrayed in Table 1 vary according to
whether the outcomes of interested are (i) rare or fre-
quent events; (ii) whether their average durations are
long or short; and (iii) if they are equal or unequal
according to exposure group. The time units and preva-
lences specified in the scenarios are described in the
table footnotes and are jointly meaningful. Note that
given the specified values – P1 and P0; T1 and T0;a n d
Δt –, the IDR and CIR are specifically obtained through
equations (9) and (12), respectively.
Overall, the PR estimate is only consistent with the IDR
and the CIR in very restricted situations. Table 1 shows
that there is only proximity when the outcome is rare and
its duration long and alike across exposure strata (scenario
1). In a still more constrained condition – when the out-
come is rare, short and of equal duration (scenario 3) –
only the IDR is numerically compatible with the PR,
whereas the CIR is already quite far-off (9.5% attenuation).
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depicted in Figure 1, which shows how the latter varies
according to the duration of outcome, given fixed preva-
lences among exposure groups and time period (Δt)
concerning the risks involved in the projected CIR.
Bearing that the straight dotted line in the centre of the
figure indicates the ‘constant’ PR = 2.0 that would be
uncovered in several cross-sectional studies, note that
the CIR is met in just a very narrow range of outcome
durations, strictly reaching equality only when
TT 10 06 9 == . . Note that arrows are indicative of the
combinations shown in scenarios 5 and 7 of Table 1.
Figure 1 Projected Cumulative Incidence Ratio (CIR) according to increasing disease durations (Ti ), given surveys uncovering P1 = 0.5
and P0 = 0.25 (PR = 2.0), and Δt=1 .
Table 1 Eight scenarios depicting cross-sectional studies carried out in different underlying conditions, yet all
uncovering prevalence ratios between exposed and non-exposed groups of 2.0
Scenario Type of outcome event Duration of outcome (Ti ) IDR * CIR **
1 Rare Long and equal 2.053 (+2.6) 2.025 (+1.2)
2 Rare Long and unequal 0.205 (-89.7) 0.227 (-88.6)
3 Rare Short and equal 2.053 (+2.6) 1.809 (-9.5)
4 Rare Short and unequal 0.205 (-89.7) 0.443 (-77.8)
5 Common Long and equal 3.000 (+50.0) 2.230 (+11.5)
6 Common Long and unequal 0.300 (-85.0) 0.656 (-67.2)
7 Common Short and equal 3.000 (+50.0) 1.037 (-48.1)
8 Common Short and unequal 0.300 (-85.0) 1.000 (-50.0)
* In brackets: % bias (IDR) calculated as [-(PR - IDR )/PR]*100, where PR = 2.0 is fixed.
** In brackets: % bias (CIR) calculated as [-(PR - CIR )/PR]*100, where PR = 2.0 is fixed.
Time units used in the scenarios
Average duration of outcome long and equal ® T1 = T0 =1
Average duration of outcome long and unequal ® T1 =1 ;T0 =0 . 1
Average duration of outcome short and equal ® T1 = T0 =0 . 1
Average duration of outcome short and unequal ® T1 = 0.1; T0 = 0.01
Time interval for projecting CIR ® Δt =1
Prevalences according to exposure group and outcome frequency
Rare outcome ® P1 = 0.05; P0 = 0.025
Common outcome ® P1 = 0.5; P0 = 0.25
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than standing for the CIR, the PR may capture the IDR
i n s t e a d .T h ed o t t e dl i n ea tt h et o po fF i g u r e1s h o w s
that the projected IDRs are quite afar from the PR. In
this scenario the latter blatantly underestimates the for-
mer by 50% throughout the Ti range, clearly not sup-
porting the above proposition. Although one may argue
that the PR tends to converge to the IDR as the out-
come event gets rarer, the question remains as to ‘how
rare should an outcome be’ in order to enable one to
accept the PR as a consistent proxy to the causal effect
parameter.
The discrepancy between the PR and the CIR may be
made more poignantly from yet another angle. Figure 2
extends Figure 1 by showing how the CIR departs from
the PR, not only in regards to the outcome duration
(Ti), but also according to the risk period of follow up
(Δt) to which the PR is referred to. Placed again within
a plausible survey context (P1 = 0.5 and P0 =0 . 2 5 ) ,F i g -
ure 2 portrays 10 Δt-scenarios. As before, on the whole,
the detected PRs (= 2.0) imply an immense gamut of
CIR estimates. In situations where Δt assumes relatively
short cumulative risk periods, the CIRs corresponding
to the PR = 2 go to extremes, be it under or overesti-
mating the latter as Ti progressively increases. As the
Δt-risk increases, the PR tends to gradually overestimate
the CIR. In the ‘extreme’ Δt = 5 condition (last graph in
Figure 2), all surveys detecting a PR = 2.0 would overes-
timate the CIR whatever the value of Ti.
Almost all scenarios depicted in Figure 2 suggest that
there are certain combinations wherein the curves cross
the lower dotted line demarcating the detected PR. This
shows that there is always a prospect of finding a PR
estimate that is close to the ‘true’ CIR in a survey nested
into a particular fixed population follow up (cohort), e.
g., Ti =0 . 4i fΔt=0 . 5 ;o rTi =1 . 1i fΔt = 1.5; or Ti =
1.7 if Δt=2 . 5 ;o rTi =2 . 0i fΔt = 3.0; or Ti =2 . 7 5i f
Δt = 4.0. However, even if one knows something about
the outcome’sd u r a t i o n(TTT i == 10 ), it is never possi-
ble to specify to which Δt-risk the PR really relates to.
Having carried out a survey and estimating the contrast
between two prevalences (exposed and unexposed), the
Figure 2 Projected Cumulative Incidence Ratio (CIR) according to increasing disease durations (Ti ) and increasing risk periods (Δt),
given surveys uncovering P1 = 0.5 and P0 = 0.25 (PR = 2.0).
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iod the risks account for and thus, by extension, the
ensuing CIR purportedly emulated by the PR.
At this point one should recall an essential question
posed before. In a survey, what would the interpretation
of a prevalence contrast be in terms of a CIR (relative
risk) on detecting, for instance, a PR = 2.0 as a proxy to
a CIR = 2.0 in a scenario akin to scenario 5 of Table 1?
One line of thought would be to picture this survey
accommodated within another study carried out on a
fixed population (cohort) in steady-state and installed in
t0 but already followed for Δt = 1.45 (e.g., year), gov-
erned by constant forces of morbidity of ID0 =0 . 3 3 3
and ID1 = 1.0 (i.e., IDR = 3). The detected PR = 2.0
w o u l dt h e nr e p r e s e n taC I Ro f2 . 0 ,t h ee s t i m a t et h a t
would have been found in t1.45 if the closed and intact
population were effectively followed up for the specified
Δt (1.45 year). This situation is signaled with an arrow
in Figure 3.
At close scrutiny, though, this quite attractive appraisal
is untenable. From the stance of a relative risk (CIR) inter-
pretation, a researcher uncovering a PR = 2.0 cannot
know which Δt is at issue. The assumption that Δt = 1.45
is empirically unrecognizable, as is thus the interpretation
itself. Counter to a common view, a detected prevalence
estimate may not be referred to any risk estimate. The key
point is that prevalences have little bearing to the CIR,
which comes to show that, beyond any numerical
discrepancy, the interpretation of PR in terms of a CIR
also implies a conceptual misunderstanding.
Turning to another scenario, what is being measured
given the conditions portrayed in Figure 3 when, for
instance, a researcher faces a PR = 2.0? Let us focalize,
for instance, the particular moment t5 when Δt = 5. Here,
the PR would be attempting to report a situation depict-
ing an underlying force of morbidly of IDR = 3, wherein
subjects installed at t0 were followed through t5,a n d
upon which the obtained CIR would be 1.225; CI0 =
0.811 and CI1 = 0.993; and TT 10 1 == .T h i si sv e r yd i f -
ferent from the PR = 2.0 obtained in the survey at this
point in time. Another key issue to emphasize, therefore,
is that it is necessary to specify which scenario a PR esti-
mate is referred to, something that is unfeasible in most
real life circumstances. Prevalence ratios may well be cal-
culated in a particular cross-sectional study, but within a
causal model framework, in general, their interpretation
is neither that of risk ratios (CIR) nor of rate ratios (IDR).
The auspicious news, though, is that the directly cal-
culated POR consistently estimates the IDR (equation
(10)) if the supporting pillars effectively hold. Given the
prevalence used in all 3 figures displayed in this subsec-
tion, POR = [P1 ×( 1-P0)]/[P0 ×( 1-P1)] = [0.5 × (1 -
0.25)]/[0.25 × (1 - 0.5)] = 3.0, which is consistent with
the underlying IDR (top dotted lines). Examining Figure
2 in particular, the equality stands whatever Ti and Δt
is involved.
Figure 3 Projected Cumulative Incidence by exposure group (CI1 and CI0) and ensuing Cumulative Incidence Ratio (CIR), according to
increasing risk periods (Δt), given surveys detecting P1 = 0.5 and P0 = 0.25 (PR = 2.0), and TT 10 1 == .
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Considering the arguments so far, one has to question
the option to unconditionally take the analysis a step
further and, without any scrutiny, model the PR. If its
meaning in terms of both the CIR and IDR is indefensi-
ble in most situations, what would thus be inferable
from a non-causal estimate accounting (controlling) for
several variables? Apart from very exceptional (and
eccentric) circumstances in which a cross-sectional
approach were used to study a rare outcome – when
the PR tends to the IDR –, the best answer perhaps
should be an uncompromising “not much"! Whichever
modeling procedure is used – whether robust Poisson
or Cox, or log-binomial models –, the PR rarely accom-
plishes its purpose in providing a meaningful estimate
within the potential outcomes model framework. On the
other hand, if the conditions for causal inference from
cross-sectional data are fulfilled and the POR effectively
and consistently estimates the IDR, the logistic regres-
sion model will provide an unbiased estimate, indepen-
dently of any “rare disease assumption”.I ti st h e
‘natural’ choice once the potential outcome model is
held.
An exception whereby models like the robust Poisson,
Cox, or log-binomial may be suitable for modeling data
arising from a cross-sectional approach is when one is
able to retrospectively reconstitute the entire empirical
experience of a fixed population. This may be the case if
it is possible to retrieve information by recall, not at all
different from a retrospective non concurrent cohort
study in which one is recovering the history of a fixed
population by way of health service records. This recall
would be informing about what happened ‘backwards in
time’ although incident cases taking place at some ear-
lier point would only be counted at the moment of
interviewing, irrespectively of when cases occurred
between time of inception (t0) and time of interview (t1).
One contention is that some subjects – whether
exposed or non-exposed – would initiate this potential
‘closed population’ follow up, but would eventually not
reach t1 (for instance, in a sample of women interviewed
at birth about an outcome event occurring during preg-
nancy). However, if this missingness is only conditional
on exposure status and not on the outcome (i.e., missing
data is random, either completely at random – MCAR –
or just at random – MAR [31]), the proportions
excluded should be balanced across exposure-outcome
combinations, so that the frequency of outcome cases
remains the same across exposure groups. Accordingly,
the subjects accrued and observed at t1 do not stand for
prevalent and non prevalent cases (by exposure group),
but rather provide unbiased information on incidence as
in the ‘complete’ cohort that would have been installed
before any withdrawal took place (as abortion would be
in the example above).
Thus, if the sample is complete or non differential
missingness holds, the design may be characterized as a
classical ‘fixed population’ retrospective cohort, with
e x p o s e da n dn o n - e x p o s e dc o h o r t si n s t a l l e da tt0;o u t -
comes occurring along Δt and being eventually mea-
sured and counted at t1. This typifies incident cases and
thus the causal measure of interest should be the CIR
rather than the PR. To emphasize, although the
approach is cross-sectional (at t1), information concerns
a cohort moving through time. Also note that, besides
an identifiable inception moment – t0 –,t h e r ei sa l s oa
clearly identifiable follow-up period – Δt – as there
should be to effectively obtain a CIR.
Decision tree for analyzing cross-sectional data
Building on the arguments provided so far, Figure 4
proposes a set of steps to be followed on deciding which
measure to use when data is collected through a cross-
sectional approach. If the purpose is genuinely to study
prevalences in population subgroups, then simple uni or
bivariate analysis will suffice. As presented in the section
on the purpose of cross-sectional studies, sometimes
probability prediction models will also be useful.
Yet, given the aim is to use a cross-sectional approach
to assess causality and the outcome is rare, whichever
estimator is chosen will be adequate. Alas, rare outcome
events are hardly ever studied in surveys. Outcomes are
usually common and in this case, a crucial first step is
to ask whether the structuring assumptions previously
outlined are actually met. If not, there is little one can
do and for practical reasons one has to clearly opt for a
descriptive perspective at the most (although this is not
less important from a public health perspective).
If all conditions are met – population is in steady
state/stationary; there is no selective survival; mean
duration is the same in both exposure groups; there is
no reverse causality; and temporal directionality from
the exposure to the outcome is sustainable –,t h e
researcher has then to figure out if there is enough
information available to recognize the time frame of the
underlying population, including several time-related
references such as t0 and Δt.
If there is information on this time frame, the next
step is to identify which variable is under focus as the
exposure of interest in the analysis. If the researcher is
fairly confident that the studied exposure is referred to
the beginning of the presumed de jure reconstituted fol-
low up window and the individual risk periods are
definable, then the analysis is analogous to a retrospec-
tive cohort study. For instance, if birth weight is the
exposure of interest (vis-à-vis a childhood development
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Page 9 of 12benchmark as outcome such as sitting unaided) and is
retrieved from mothers of children one year of age, the
researcher may be quite confident that s/he is capturing
information regarding an exposure at the inception of
the cohort that is being ‘reconstituted’–birth – and
that a recognizable ‘closed’ follow up period is demar-
cated – 1 year. In so being, the measure of interest is
the CIR and the robust Poisson, Cox or log-binomial
models are perhaps the most suitable ensuing multivari-
able models.
Another possibility is that the exposure of interest
may not be informative of an event occurring at t0 and
started someway along the reconstructed follow up per-
iod (Δt). Given that the timing of exposure occurrence
te lies within Δt( t0 <te <t1), individual follow up times
may no longer be equal and as a consequence some
subjects would not be observed for the whole risk per-
iod. Since this is equivalent to an unequal person-time
apportionment in a prospective study design, the possi-
bility of studying risk (CIi) is no longer possible. The
same applies if the exposure of interest changes status
along Δt and/or if the potential time of follow up varies
across subjects.
Strictly, these scenarios are akin to that obtained in the
vast majority of cross-sectional studies whereby data refers
to a dynamic population and the time frame of an under-
lying followed up population is simply not recoverable. In
all these situations, provided the structuring assumptions
are tenable, the analysis proceeds as in a density sampling
case-control study wherein non-prevalent cases are pro-
portional to respective person-time quantities and ulti-
mately sustain an unbiased estimate of the IDR through
the calculated cross-product ratio [30,32]. Hence, as pre-
viously mentioned, the logistic model may be the most
suitable related multivariable model.
Putting it all together
In the light of our own contentions, it is worth re-exam-
ining the dispute ‘between camps’ alluded to in the
introduction. As mentioned, several arguments against
the POR have been raised [13-18]. One is that the POR
is difficult to interpret and communicate. According to
Pearce [19], Strömberg [12] and our own arguments, the
POR should not be difficult to interpret once it is
understood that the POR is an acceptable measure to
estimate the IDR, which, in turn, also implies under-
standing what the quantities represented by the preva-
lent and non-prevalent cases stand for (akin to a density
sampling case-control study [20,33]).
Another argument against the POR was that it is very
discrepant from PR when outcomes are common. We
stand with Pearce [19] in contending that “the fact that
the two methods give different results when the disease is
common [...] does not tell us which measure is more
appropriate to use“. We go beyond this assertion by put-
ting forward that it is in fact a positive aspect that the
POR is discrepant from the PR when the outcome is
common since, except for very restrictive and most
unrealistic circumstances, the latter does not stand for
much as a causal parameter, whereas the former may be
meaningful (namely, standing for the IDR) given certain
conditions – e.g., stationarity and equal duration of dis-
ease. Although, according to Thompson [18], these con-
ditions are hardly met and would thus disfavor the POR,
it is by no means clear how the PR would survive this
criticism as well, since it is also strongly affected by any
violation of these assumptions.
Yet another argument against the POR within the
context of common outcomes is that the measure is at
times misinterpreted as a cumulative incidence ratio
(CIR). In our view, it does not seem fair to blame the
measure instead of who misunderstands it. Moreover,
we believe that the same risk of misinterpretation holds
for the PR.
The remark made by some authors such as Lee [15]
that the only usefulness of POR is to mimic other ratio
measures should not be taken as a criticism, but conver-
sely, as a positive facet. If anything, it is auspicious that
the cross product ratio generated by way of a cross-sec-
tional approach is able to provide a contrast of inci-
dence measures in some conditions, which is unlikely to
occur with the PR. By extension, coefficients obtained in
a logistic regression should be regarded as multivariate
cross-product ratios that, given a causal framework,
stand for unbiased estimates of IDRs.
Beyond the points debated so far, Thompson et al.
[18] additionally argue that, given the absence of longi-
t u d i n a ld a t aa n dt h ei n a b i l i t yt om a k ep r o p e rc a u s a l
inferences once cross-sectional data will be used, it is
best to use PR because this overtly signals its “limited
inferential value“ and thus warns the reader ensuring
“truth in advertising“. Again, it is our stand that this
perspective is essentially ill-advised in regards to etiolo-
gical inference. First and foremost, conditions for causal
inference are either present (assumable) or not. If not,
there is not much reason for estimating an effect mea-
sure and label it as of ‘limited inferential value’. The dis-
cussion on the best estimator and related model only
makes sense if preceded by a thorough debate about
what is actually sought with a cross-sectional study and
what the ensuing best measures for inference are. If the
assumptions for etiological inference do not hold, there
is no reason for modeling data in order to control for
confounding. Dealing with confounders has no meaning
outside a causal reasoning and is only justified under a
counterfactual logic [28,34].
The growing literature on alternative multivariable
models to estimate effects arising from cross-sectional
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opment of epidemiological research, on the contrary,
may have brought more shadows than light on the mat-
ter. Not because the intricacies of the proposed models
are incorrect, but because the importance of actual epi-
demiological model building have been largely side-
stepped. The conditions and appropriateness for
modeling are taken for granted, yet as this paper
attempts to remind, considering theoretically based
putative relations between the events of interest is cru-
cial to the process. Outcomes and exposures, as well as
other elements involved in the causal system – confoun-
ders, effect modifiers, mediators, colliders [30,35] – not
only require assessment on matters of substance and
meaning, but also in regards to their temporal relations
within the time frame of any given study. Only then are
decisions to be taken in favor of any statistical model.
And given the recognizably restricted situations where
causal modeling is indeed obtainable from cross sec-
tional data, the POR – or rather, the calculated cross
product ratio as an estimate of the IDR – ought to be
the most widely indicated estimator.
Summary
During the last two decades the choice between Preva-
lence Ratio (PR) and Prevalence Odds Ratio (POR) to
contrast exposure groups in cross-sectional studies has
been the subject of debate. In the last 10 years, this
debate became more focused on the choice between dif-
ferent regression models for estimating PR. In this paper
we used different scenarios to illustrate and sustain our
point of view concerning two issues related to the analy-
sis of cross-sectional data. Firstly, when conditions for
causal inference in cross-sectional studies do not hold,
crude or subgroup prevalences are the quantities to be
presented. Secondly, when the assumptions for causal
inference are met, two additional aspects need to be
considered: (i) cumulative incidence ratio (CIR) is not
properly estimated using either PR or POR; (ii) the only
measure that provides an unbiased estimate of incidence
density ratio (IDR) is the POR. An exception for these
two statements is the presence of rare diseases, which
usually are not subject of surveys. Based on these facts,
we sustain that multivariate modeling should be
restricted to scenarios were assumptions for causal
inference from cross-sectional studies effectively hold
and that for such cases the logistic regression model
remains the appropriate choice to capture the incidence
contrast between exposure groups.
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